搜尋結果
2022
Zhang, J. ,
Chang, C. L. ,
Lu, C. Y. ,
Chen, H. M. &
Wu, S. Y. ,
3月 3 2022 ,
於: Frontiers in Oncology. 12 , 708632.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Simple Mastectomy
100%
Propofol
73%
Conduction Anesthesia
54%
Anesthesia
54%
Carcinoma, Ductal, Breast
46%
Sun, M. ,
Lin, J. A. ,
Chang, C. L. ,
Wu, S. Y. &
Zhang, J. ,
2022 , (接受/付印)
於: British Journal of Anaesthesia. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Propensity Score
100%
Chronic Pain
84%
Opioid Analgesics
82%
Cohort Studies
63%
Neoplasms
30%
Sun, M. ,
Chang, C. L. ,
Lu, C. Y. ,
Zhang, J. &
Wu, S. Y. ,
4月 2022 ,
於: British Journal of Anaesthesia. 128 ,
4 ,
p. 708-717 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Propensity Score
100%
Chronic Pain
84%
Opioid Analgesics
82%
Cohort Studies
63%
Survival
51%
Intercellular Signaling Peptides and Proteins
100%
RNA
79%
genes
77%
Long Noncoding RNA
71%
Transforming Growth Factors
69%
Ingenol Mebutate
100%
3-ingenyl angelate
83%
S100 Calcium-Binding Protein A4
77%
Colorectal Neoplasms
38%
Protein
19%
Sun, M. Y. ,
Chang, C. L. ,
Lu, C. Y. ,
Wu, S. Y. &
Zhang, J. Q. ,
5月 1 2022 ,
於: Nutrients. 14 ,
9 , 1910.
研究成果: 雜誌貢獻 › 文章 › 同行評審
sarcopenia
100%
cohort studies
75%
Sarcopenia
68%
Propensity Score
58%
risk factors
53%
Lai, I. C. ,
Liao, C. H. ,
Hu, M. H. ,
Chang, C. L. ,
Lai, G. M. ,
Chiou, T. J. ,
Hsia, S. ,
Tsai, W. L. ,
Lin, Y. Y. ,
Chuang, S. E. ,
Whang-Peng, J. ,
Chen, H. Y. &
Yao, C. J. ,
8月 2022 ,
於: Nutrients. 14 ,
15 , 3232.
研究成果: 雜誌貢獻 › 文章 › 同行評審
cisplatin
100%
Fish Oils
94%
Selenium
85%
A549 Cells
85%
fish oils
82%
Sun, M. ,
Chang, C. L. ,
Lu, C. Y. ,
Wu, S. Y. &
Zhang, J. ,
3月 2022 ,
於: Journal of Personalized Medicine. 12 ,
3 , 384.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Tramadol
100%
Propensity Score
84%
Chronic Pain
71%
Cohort Studies
53%
Analgesics
52%
2021
Chiu, K. C. ,
Lin, W. C. ,
Chang, C. L. &
Wu, S. Y. ,
7月 1 2021 ,
於: Cancers. 13 ,
13 , 3231.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chemoradiotherapy
100%
Lung Diseases
83%
Squamous Cell Carcinoma
78%
Survival
51%
Lung
50%
Zhang, J. ,
Chang, C. L. ,
Lu, C. Y. ,
Chen, H. M. &
Wu, S. Y. ,
10月 2021 ,
於: Biomedicine and Pharmacotherapy. 142 , 111991.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Conduction Anesthesia
100%
Propofol
90%
General Anesthesia
76%
Carcinoma, Ductal, Breast
56%
Breast Neoplasms
53%
Lawal, B. ,
Liu, Y. L. ,
Mokgautsi, N. ,
Khedkar, H. ,
Sumitra, M. R. ,
Wu, A. T. H. &
Huang, H. S. ,
2021 ,
於: Biomedicines. 9 ,
1 ,
p. 1-22 22 p. , 92.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Salicylanilide
100%
Tumor Cell Line
58%
Antitumor
53%
salicylanilide
44%
STAT3 Transcription Factor
41%
Chien, Y. N. ,
Lin, Y. C. ,
Chang, C. L. ,
Lin, W. C. &
Wu, S. Y. ,
12月 2021 ,
於: Lung Cancer. 162 ,
p. 29-35 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Adenocarcinoma of Lung
100%
ErbB Receptors
89%
Protein-Tyrosine Kinases
85%
Thoracic Surgery
84%
Survival
51%
Wang, W. J. ,
Lee, K. D. ,
Lu, L. S. ,
Ting, L. L. &
Chiou, J. F. ,
3月 2021 ,
於: Therapeutic Radiology and Oncology. 5 ,
March , 5.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Neuroendocrine Carcinoma
100%
Immunotherapy
68%
Radiotherapy
53%
Neoplasm Metastasis
47%
Liver
39%
Liu, C. H. ,
Wong, S. H. ,
Tai, C. J. ,
Tai, C. J. ,
Pan, Y. C. ,
Hsu, H. Y. ,
Richardson, C. D. &
Lin, L. T. ,
1月 1 2021 ,
於: Cancers. 13 ,
1 ,
p. 1-19 19 p. , 136.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Oncolytic Virotherapy
100%
ursolic acid
95%
Measles
73%
Nanoparticles
57%
Measles virus
52%
2020
Chen, S. H. ,
Hsieh, Y. Y. ,
Tzeng, H. E. ,
Lin, C. Y. ,
Hsu, K. W. ,
Chiang, Y. S. ,
Lin, S. M. ,
Su, M. J. ,
Hsieh, W. S. &
Lee, C. H. ,
5月 29 2020 ,
於: Cancers. 12 ,
6 , 1399.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
100%
Myeloid Cells
97%
Carcinogenesis
72%
Viruses
45%
In Vitro Techniques
41%
Liao, C. H. ,
Yong, C. Y. ,
Lai, G. M. ,
Chow, J. M. ,
Cheng, C. F. ,
Fang, C. L. ,
Lin, P. C. ,
Chang, C. L. ,
Zheng, Y. M. ,
Chuang, S. E. ,
Whang-Peng, J. &
Yao, C. J. ,
2020 ,
於: American Journal of Chinese Medicine. 48 ,
6 ,
p. 1491-1509 19 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Macrophage Migration-Inhibitory Factors
100%
Adenocarcinoma of Lung
77%
Polysaccharides
68%
Matrix Metalloproteinase 13
60%
Severe Combined Immunodeficiency
37%
Fedratinib
100%
Janus Kinase 2
72%
Janus Kinase Inhibitors
72%
Data Mining
62%
Oncogenes
48%
Hsieh, Y. Y. ,
Fang, W. T. ,
Lo, Y. W. ,
Chen, Y. H. &
Chien, L. N. ,
8月 15 2020 ,
於: International Journal of Cancer. 147 ,
4 ,
p. 1107-1116 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Afatinib
100%
Gefitinib
82%
Taiwan
77%
Epidermal Growth Factor
77%
Non-Small Cell Lung Carcinoma
70%
Wang, C. Q. ,
Tang, C. H. ,
Tzeng, H. E. ,
Jin, L. ,
Zhao, J. ,
Kang, L. ,
Wang, Y. ,
Hu, G. N. ,
Huang, B. F. ,
Li, X. ,
Zhao, Y. M. ,
Su, C. M. &
Jin, H. C. ,
1月 1 2020 ,
於: Journal of Cancer. 11 ,
10 ,
p. 2769-2777 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Genetic Polymorphisms
100%
Breast Neoplasms
60%
Single Nucleotide Polymorphism
53%
Alleles
15%
Genotype
15%
Chang, T. S. ,
Tsai, Y. H. ,
Lin, Y. H. ,
Chen, C. H. ,
Lu, C. K. ,
Huang, W. S. ,
Yang, Y. H. ,
Chen, W. M. ,
Hsieh, Y. Y. ,
Wu, Y. C. ,
Tung, S. Y. &
Huang, Y. H. ,
1月 1 2020 ,
於: PLoS ONE. 15 ,
2 , e0229101.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Antibiotic Prophylaxis
100%
hemorrhage
84%
confidence interval
75%
disease control
74%
antibiotics
63%
Huang, K. C. ,
Li, K. J. ,
Chang, C. L. ,
Lin, C. C. &
Cho, S. ,
2020 ,
於: Value in Health Regional Issues. 22 ,
p. S107 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lin, J. ,
Hsieh, R. K. ,
Chen, J. S. ,
Lee, K. D. ,
Rau, K. M. ,
Shao, Y. Y. ,
Sung, Y. C. ,
Yeh, S. P. ,
Chang, C. S. ,
Liu, T. C. ,
Wu, M. F. ,
Lee, M. Y. ,
Yu, M. S. ,
Yen, C. J. ,
Lai, P. Y. ,
Hwang, W. L. &
Chiou, T. J. ,
4月 1 2020 ,
於: Asia-Pacific Journal of Clinical Oncology. 16 ,
2 ,
p. e91-e98 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pain Management
100%
Quality of Life
63%
Pain
57%
Neoplasms
31%
Cancer Pain
25%
Tai, C. J. ,
Shi, Y. C. ,
Tai, C. J. ,
Kuo, L. J. ,
Chen, R. J. ,
Chang, Y. J. ,
Tzao, C. ,
Wu, C. H. ,
Chang, C. C. ,
Chiou, H. Y. &
Su, C. H. ,
3月 1 2020 ,
於: Alternative Therapies in Health and Medicine. 24 ,
12 ,
p. 18-22 研究成果: 雜誌貢獻 › 文章 › 同行評審
Amphotericin B
100%
Drug Therapy
53%
Response Evaluation Criteria in Solid Tumors
32%
Ethanol
32%
Neoplasms
29%
Tai, C. J. ,
Jassey, A. ,
Liu, C. H. ,
Tai, C. J. ,
Richardson, C. D. ,
Wong, S. H. &
Lin, L. T. ,
4月 8 2020 ,
於: Cells. 9 ,
4 研究成果: 雜誌貢獻 › 文章 › 同行評審
Berberine
100%
Autophagy
71%
Hepacivirus
68%
Hepatocellular Carcinoma
59%
Cell Death
56%
2019
Chang, C. L. ,
Yuan, K. S. P. ,
Wu, A. T. H. &
Wu, S. Y. ,
12月 2019 ,
於: Cancers. 11 ,
12 , 2003.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Propensity Score
100%
Colon
74%
Adenocarcinoma
73%
Cohort Studies
63%
Population
36%
Tai, C. J. ,
Liu, C. H. ,
Pan, Y. C. ,
Wong, S. H. ,
Tai, C. J. ,
Richardson, C. D. &
Lin, L. T. ,
12月 1 2019 ,
於: Scientific Reports. 9 ,
1 , 6767.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Oncolytic Viruses
100%
Camptothecin
94%
Measles virus
91%
Breast Neoplasms
45%
Oncolytic Virotherapy
15%
Chen, S. H. ,
Chow, J. M. ,
Hsieh, Y. Y. ,
Lin, C. Y. ,
Hsu, K. W. ,
Hsieh, W. S. ,
Chi, W. M. ,
Shabangu, B. M. &
Lee, C. H. ,
5月 1 2019 ,
於: International Journal of Molecular Sciences. 20 ,
9 , 2271.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylases
100%
Panobinostat
92%
Cell death
66%
apoptosis
62%
K562 Cells
53%
Pituitary Neoplasms
100%
Renal Cell Carcinoma
88%
Oncogenes
87%
Computer Simulation
86%
Messenger RNA
13%
Hsieh, Y. Y. ,
Liu, T. P. ,
Chou, C. J. ,
Chen, H. Y. ,
Lee, K. H. &
Yang, P. M. ,
9月 28 2019 ,
於: Genes. 10 ,
10 , 766.
研究成果: 雜誌貢獻 › 文章 › 同行評審
gemcitabine
100%
Computational Biology
84%
Cell Cycle
70%
Adenocarcinoma
70%
Gene Deletion
15%
Chen, J. C. ,
Hsieh, Y. Y. ,
Lo, H. L. ,
Li, A. ,
Chou, C. J. &
Yang, P. M. ,
9月 9 2019 ,
於: Biomolecules. 9 ,
9 , 467.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Computer Simulation
100%
Drug Resistance
97%
Topoisomerase Inhibitor
88%
Colorectal Neoplasms
84%
Etoposide
56%
pardaxin
100%
Cell Proliferation
32%
Toll-Like Receptor 2
20%
U937 Cells
20%
Leukemia
20%
Lin, L. T. ,
Uen, W. C. ,
Choong, C. Y. ,
Shi, Y. C. ,
Lee, B. H. ,
Tai, C. J. &
Tai, C. J. ,
6月 3 2019 ,
於: Molecules. 24 ,
11 , 2102.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Paris
100%
Doxorubicin
85%
drugs
83%
Autophagy
79%
Pennogenin
78%
Lin, R. K. ,
Choong, C. Y. ,
Hsu, W. H. ,
Tai, C. J. &
Tai, C. J. ,
6月 2019 ,
於: African Health Sciences. 19 ,
2 ,
p. 2156-2163 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cordyceps
100%
Mycelium
87%
Polysaccharides
60%
Doxorubicin
59%
Drug Therapy
38%
Wu, H. J. ,
Tai, C. J. ,
Tai, C. J. &
Chien, L. Y. ,
1月 2019 ,
於: European Journal of Cancer Care. 28 ,
1 , e12925.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Complementary Therapies
100%
Taiwan
97%
Colorectal Neoplasms
78%
Breast Neoplasms
62%
Cancer Survivors
33%
Testicular Germ Cell Tumor
100%
Seizures
56%
Brain Neoplasms
44%
Drug Therapy
42%
Brain
35%
Chang, C. L. ,
Yuan, K. S. P. ,
Wu, A. T. H. &
Wu, S. Y. ,
11月 2019 ,
於: Cancers. 11 ,
11 , 1658.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Radiosurgery
100%
Radiotherapy
62%
Optic Nerve Injuries
42%
Stroke
41%
Regression Analysis
39%
Kuo, C. Y. ,
Lin, S. H. ,
Lee, K. D. ,
Cheng, S. J. ,
Chu, J. S. &
Tu, S. H. ,
7月 27 2019 ,
於: BMC Surgery. 19 ,
1 , 100.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Phyllodes Tumor
100%
Hemangiosarcoma
86%
Breast Neoplasms
43%
Thoracic Wall
42%
Skin Transplantation
24%
2018
Chen, T. W-W. ,
Yeh, D-C. ,
Chao, T-Y. ,
Lin, C-H. ,
Chow, L. W-C. ,
Chang, D-Y. ,
Hsieh, Y-Y. ,
Huang, S-M. ,
Cheng, A-L. &
Lu, Y-S. ,
3月 1 2018 ,
於: Japanese Journal of Clinical Oncology. 48 ,
3 ,
p. 242-247 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lapatinib
100%
Vinorelbine
94%
Breast Neoplasms
45%
Neutropenia
8%
Diarrhea
7%
Uen, W-C. ,
Shi, Y-C. ,
Choong, C-Y. &
Tai, C-J. ,
8月 15 2018 ,
於: Journal of Food Biochemistry. 0 ,
0 ,
p. e12569 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hsieh, C. I. ,
Kuo, R. N. C. ,
Liang, C. C. ,
Tsai, H. Y. &
Chung, K. P. ,
12月 1 2018 ,
於: BMJ Open. 8 ,
12 , 021341.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Adjuvant Chemotherapy
100%
Taiwan
97%
Colonic Neoplasms
89%
Physicians
62%
Population
38%
Uen, W. C. ,
Lee, B. H. ,
Shi, Y. C. ,
Wu, S. C. ,
Tai, C. J. &
Tai, C. J. ,
2018 ,
於: Journal of Traditional and Complementary Medicine. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Solanum nigrum
100%
Mitochondrial Dynamics
72%
Mouth Neoplasms
61%
Squamous Cell Neoplasms
19%
Cell Proliferation
10%
Wang, C-K. ,
Chen, H-C. ,
Fang, S-U. ,
Ho, C-W. ,
Tai, C-J. ,
Yang, C-P. &
Liu, Y-C. ,
12月 1 2018 ,
於: Scientific Reports. 8 ,
1 ,
p. 6316 6316.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Drinking
100%
Lung Neoplasms
86%
Water
73%
Cisplatin
37%
Drinking Water
27%
Lin, Y. K. ,
Hsieh, M. C. ,
Chang, C. L. ,
Chow, J. M. ,
Yuan, K. S. P. ,
Wu, A. T. H. &
Wu, S. Y. ,
11月 1 2018 ,
於: Radiotherapy and Oncology. 129 ,
2 ,
p. 326-332 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Intensity-Modulated Radiotherapy
100%
Propensity Score
88%
Adenocarcinoma
64%
Cohort Studies
56%
Drug Therapy
48%
Cheng, W. L. ,
Huang, C. Y. ,
Tai, C. J. ,
Chang, Y. J. &
Hung, C. S. ,
2月 2018 ,
於: Anticancer Research. 38 ,
2 ,
p. 863-870 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
SERPIN-B5
100%
Curcumin
71%
Prostatic Neoplasms
49%
Hormones
43%
PC-3 Cells
43%
Kao, R. H. ,
Lai, G. M. ,
Chow, J. M. ,
Liao, C. H. ,
Zheng, Y. M. ,
Tsai, W. L. ,
Hsia, S. ,
Lai, I. C. ,
Lee, H. L. ,
Chuang, S. E. ,
Whang-Peng, J. &
Yao, C. J. ,
10月 8 2018 ,
於: Nutrients. 10 ,
10 , 1458.
研究成果: 雜誌貢獻 › 文章 › 同行評審
AMP-activated protein kinase
100%
Fish Oils
89%
AMP-Activated Protein Kinases
86%
adenocarcinoma
86%
Selenium
80%
Wang, S. W. ,
Chen, Y. R. ,
Chow, J. M. ,
Chien, M. H. ,
Yang, S. F. ,
Wen, Y. C. ,
Lee, W. J. &
Tseng, T. H. ,
7月 2018 ,
於: Molecular Carcinogenesis. 57 ,
7 ,
p. 866-877 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Luteolin
100%
Fas Ligand Protein
86%
HL-60 Cells
83%
Acetylation
75%
Histones
66%
Liu, T. P. ,
Hsieh, Y. Y. ,
Chou, C. J. &
Yang, P. M. ,
11月 1 2018 ,
於: Royal Society Open Science. 5 ,
11 ,
p. 181321 181321.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Polypharmacology
100%
Drug Repositioning
82%
Databases
36%
Pharmaceutical Preparations
20%
Topoisomerase Inhibitors
15%
Diabetic Ketoacidosis
100%
Type 1 Diabetes Mellitus
69%
Diabetes Mellitus
31%
Esophagogastric Junction
25%
Nausea
17%
2017
Lai, I. C. ,
Lai, G. M. ,
Chow, J. M. ,
Lee, H. L. ,
Yeh, C. F. ,
Li, C. H. ,
Yan, J. L. ,
Chuang, S. E. ,
Whang-Peng, J. ,
Bai, K. J. &
Yao, C. J. ,
11月 15 2017 ,
於: Chinese Medicine (United Kingdom). 12 ,
1 , 33.
研究成果: 雜誌貢獻 › 文章 › 同行評審
MAP Kinase Signaling System
100%
Non-Small Cell Lung Carcinoma
81%
Lung Neoplasms
72%
n-hexane
36%
Protein-Tyrosine Kinases
23%
Tai, C. J. ,
Wang, H. ,
Wang, C. K. ,
Tai, C. J. ,
Huang, M. T. ,
Wu, C. H. ,
Chen, R. J. ,
Kuo, L. J. ,
Wei, P. L. ,
Chang, Y. J. ,
Chang, C. C. ,
Chiou, H. Y. &
Wu, C. J. ,
5月 1 2017 ,
於: Clinical and Experimental Medicine. 17 ,
2 ,
p. 141-150 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Gemcitabine
100%
Cetuximab
83%
Bevacizumab
74%
Cisplatin
72%
Tumor Burden
63%